Advertisement
Journal Home
Search for

Volume 39, Issue 13, Pages 1861-1865 (September 2003)


View previous. 3 of 24 View next.

Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas

on behalf of the EORTC Melanoma groupA SpatzaCorresponding Author Informationemail address, M.G Cookb, D.E Elderc, M Piepkornd, D.J Ruitere, R.L Barnhillf

Received 29 January 2003; accepted 21 February 2003.

Abstract 

In the recently revised melanoma staging system proposed by the American Joint Committee on Cancer (AJCC), ulceration assessment by the pathologist is a pivotal parameter. Patients upstaged because of ulceration might be included in adjuvant trials conducted in AJCC stage II melanoma patients. Therefore, accuracy based on interobserver reproducibility for melanoma ulceration assessment is crucial for proper clinical management. In some cases, it is extremely difficult, even for an experienced pathologist, to distinguish between trauma-induced ulceration, artifact and tumoral ulceration. Whether this difficulty may be resolved by the use of a more precise definition of ulceration has not been evaluated. Therefore, we have proposed a refined definition of melanoma ulceration and we tested whether this definition might improve the interobserver interpretative reproducibility of ulceration in primary cutaneous melanomas. The results of this study support the need for a more precise definition of melanoma ulceration that rules out biopsy trauma or processing artifact and could be incorporated into a standardised pathology worksheet for reporting primary melanomas.

a Institut Gustave-Roussy, Villejuif, France

b Royal Surrey County Hospital, Guildford, UK

c University of Pennsylvania School of Medicine, Philadelphia, PA, USA

d University of Washington, Seattle, WA, USA

e University Medical Center St-Radboud, Nijmegen, The Netherlands

f The George Washington Medical Center, Washington, DC, USA

Corresponding Author InformationCorresponding author. Tel.: +33-1-4211-4462; fax: +33-1-4211-5263

PII: S0959-8049(03)00325-3

doi:10.1016/S0959-8049(03)00325-3


View previous. 3 of 24 View next.